If you made any changes in Pure these will be visible here soon.

Personal profile


Owen Tan has background in molecular biology, health and commerce. His specific research interests include the economic impact of new technology in healthcare. His recent research focuses on developing microsimulation model to analyse the economic cost of implementing next-generation sequencing in patient care.

Fingerprint Dive into the research topics where Owen Tan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Neuroblastoma Medicine & Life Sciences
Retinoids Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Cell Movement Medicine & Life Sciences
Cells Chemical Compounds
Fenretinide Medicine & Life Sciences
Caspase 2 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2017 2019

Research Outputs 2009 2019

  • 225 Citations
  • 9 h-Index
  • 14 Article

Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis

Sutton, S. K., Cheung, B. B., Massudi, H., Tan, O., Koach, J., Mayoh, C., Carter, D. R. & Marshall, G. M., 4 Sep 2019, In : Journal of cancer research and clinical oncology. 145, 9, p. 2241-2250 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Lymph Nodes
Neoplasm Metastasis

A Brief, global history of microsimulation models in health: past applications, lessons learned and future directions

Schofield, D. J., Zeppel, M. J. B., Tan, O., Lymer, S., Cunich, M. M. & Shrestha, R. N., 1 Mar 2018, In : International Journal of Microsimulation. 11, 1, p. 97-142 46 p.

Research output: Contribution to journalArticleResearchpeer-review

Model Error

Application of next-generation sequencing to improve cancer management: A review of the clinical effectiveness and cost-effectiveness

Tan, O., Shrestha, R., Cunich, M. & Schofield, D. J., Mar 2018, In : Clinical Genetics. 93, 3, p. 533-544 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Cost-Benefit Analysis
Costs and Cost Analysis

A novel compound which sensitizes BRAF wild-type melanoma cells to vemurafenib in a TRIM16-dependent manner

Sutton, S. K., Carter, D. R., Kim, P., Tan, O., Arndt, G. M., Zhang, X. D., Baell, J., Noll, B. D., Wang, S., Kumar, N., McArthur, G. A., Cheung, B. B. & Marshall, G. M., 9 Aug 2016, In : Oncotarget. 7, 32, p. 52166-52178 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Small Molecule Libraries
Drug Combinations

High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients

Kim, P. Y., Tan, O., Liu, B., Trahair, T., Liu, T., Haber, M., Norris, M. D., Marshall, G. M. & Cheung, B. B., 1 May 2016, In : Cancer Letters. 374, 2, p. 315-323 9 p.

Research output: Contribution to journalArticleResearchpeer-review

DNA-Binding Proteins
Breast Neoplasms


Socioeconomic and health impacts of climate change on vulnerable populations

Melanie Zeppel (Participant), Dr Sophie Lewis (Participant), Dr Sarah Perkins-Kirkpatrick (Participant), Petra Graham (Participant), Rupendra Shrestha (Participant), Hui Ping Evelyn Lee (Participant), Owen Tan (Participant), Heather Stevens (Participant), John Nairn (Participant), Paul Beggs (Participant), Deborah Schofield (Participant), Sarah Judd-Lam (Participant)

Impact: Other impacts